Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic fibrosis.
Nanoparticle researchers develop microfluidic platform for better delivery of gene therapy for lung disease
Posted in biotech/medical, nanotechnology